S L Ferrari
Overview
Explore the profile of S L Ferrari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
895
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
How Shing Koy E, Amouzougan A, Biver E, Chapurlat R, Chevalley T, Ferrari S, et al.
Osteoporos Int
. 2021 Nov;
33(3):711.
PMID: 34746966
No abstract available.
2.
How Shing Koy E, Amouzougan A, Biver E, Chapurlat R, Chevalley T, Ferrari S, et al.
Osteoporos Int
. 2021 Oct;
33(3):703-709.
PMID: 34642812
Introduction: High-resolution peripheral quantitative computed tomography (HR-pQCT) non-invasively measures three-dimensional bone microarchitectural parameters and volumetric bone mineral density. Previous studies established normative reference HR-pQCT datasets for several populations, but there...
3.
Bouxsein M, Zysset P, Gluer C, McClung M, Biver E, Pierroz D, et al.
Osteoporos Int
. 2020 Jan;
31(3):393-408.
PMID: 31900541
Introduction: The risk of hip fractures increases exponentially with age due to a progressive loss of bone mass, deterioration of bone structure, and increased incidence of falls. Areal bone mineral...
4.
Ferrari S, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, et al.
Osteoporos Int
. 2018 Aug;
29(12):2585-2596.
PMID: 30066131
Fragility fractures are increasingly recognized as a complication of both type 1 and type 2 diabetes, with fracture risk that increases with disease duration and poor glycemic control. Yet the...
5.
Biver E, Durosier-Izart C, Merminod F, Chevalley T, van Rietbergen B, Ferrari S, et al.
Osteoporos Int
. 2018 May;
29(8):1771-1782.
PMID: 29725715
Introduction: Fermented dairy products (FDP), including yogurts, provide calcium, phosphorus, and proteins together with prebiotics and probiotics, all being potentially beneficial for bone. In this prospective cohort study, we investigated...
6.
Pepe J, Bonnet N, Herrmann F, Biver E, Rizzoli R, Chevalley T, et al.
Osteoporos Int
. 2017 Oct;
29(2):339-346.
PMID: 29038835
Purpose: The purpose of this study is to investigate the interaction between periostin gene polymorphisms (SNPs) and other genes potentially responsible for modulating serum periostin levels and bone microstructure in...
7.
Uebelhart B, Rizzoli R, Ferrari S
Osteoporos Int
. 2017 May;
28(9):2701-2705.
PMID: 28540505
Introduction: Discontinuation of Dmab therapy is followed by a transient increase of bone turnover markers (BTMs) above pretreatment values, together with accelerated bone loss, and potentially an increased risk of...
8.
Cavalier E, Bergmann P, Bruyere O, Delanaye P, Durnez A, Devogelaer J, et al.
Osteoporos Int
. 2016 Mar;
27(7):2181-2195.
PMID: 27026330
The exact role of biochemical markers of bone turnover in the management of metabolic bone diseases remains a topic of controversy. In this consensus paper, the Belgian Bone Club aimed...
9.
MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus
Hough F, Pierroz D, Cooper C, Ferrari S
Eur J Endocrinol
. 2015 Nov;
174(4):R127-38.
PMID: 26537861
Subjects with type 1 diabetes mellitus (T1DM) have decreased bone mineral density and an up to sixfold increase in fracture risk. Yet bone fragility is not commonly regarded as another...
10.
Bouxsein M, Devlin M, Glatt V, Dhillon H, Pierroz D, Ferrari S
Endocrinology
. 2008 Sep;
150(1):144-52.
PMID: 18801900
Activation of beta2-adrenergic receptors inhibits osteoblastic bone formation and enhances osteoclastic bone resorption. Whether beta-blockers inhibit ovariectomy-induced bone loss and decrease fracture risk remains controversial. To further explore the role...